| Date | Subject |
| 10/15/2008 01:25:32 PM | |
| Older Donors Lead to Late Hepatic Artery Thrombosis in Liver Recipients: Presented at ACS |
| 10/07/2008 10:21:42 AM | |
| Patients With IBD, Chronic Liver Disease at Increased Risk of Vitamin D Deficiencies |
| 09/25/2008 04:06:22 PM | |
| Majority of Children Vaccinated Against Hepatitis B Not at Increased Risk of MS |
| 09/19/2008 02:37:50 PM | |
| CDC Expands Testing Recommendations for Chronic Hepatitis B |
| 09/19/2008 12:32:42 PM | |
| Exposure Levels of Ribavirin Similar in Paediatric and Adult Patients With Hepatitis C: Presented at ACCP |
| 09/17/2008 01:06:09 PM | |
| Cetuximab Addition Produces High Rate of Complete Responses in Colorectal Cancer Patients With Resectable Liver Metastases: Presented at ESMO |
| 09/16/2008 02:38:33 PM | |
| Higher Urinary Levels of BPA Linked With Cardiovascular Disease, Diabetes |
| 09/14/2008 03:36:58 PM | |
| Sorafenib Effective in Patients With Liver Cancer Infected With Hepatitis B: Presented at ESMO |
| 09/05/2008 02:42:20 PM | |
| Down-Staged Liver Cancer Associated With Good Post-Transplant Outcomes |
| 09/05/2008 02:40:53 PM | |
| Living Donor Liver Transplants May Drastically Decrease Mortality From Liver Failure in US |
| 09/04/2008 11:33:36 PM | |
| Normal ALT Levels May Mask Advanced Fibrosis in Liver Disease Patients |
| 09/04/2008 03:38:08 PM | |
| FDA Approves DNA Test to Measure Hepatitis B Virus Levels |
| 09/02/2008 12:46:15 PM | |
| Liver Stiffness Measurement Accurately Identifies Advanced Liver Disease Without Biopsy |
| 08/12/2008 10:02:42 AM | |
| Tenofovir Approved for Treatment of Chronic Hepatitis B in Adults |
| 07/31/2008 03:39:38 PM | |
| R1626 Plus Standard HCV Treatment Provides Potent Antiviral Effect |
| 07/31/2008 03:36:49 PM | |
| Valganciclovir Reduces Epstein-Barr Levels in Children With Liver Transplants |
| 07/23/2008 12:57:38 PM | |
| Sorafenib Improves Overall Survival in Patients With Advanced Liver Cancer |
| 07/21/2008 12:06:50 PM | |
| Livers From Elderly Donors Safe, Effective for Recipients With Hepatitis C |
| 07/10/2008 07:00:20 PM | |
| Use of HRT Patches Lowers Risk of Gall Bladder Disease Versus Oral Therapy |
| 06/30/2008 05:36:18 PM | |
| Fatty Liver Disease May Raise Heart Disease Risk in Overweight and Obese Children |
| 06/27/2008 11:55:10 AM | |
| Entecavir Safe, Effective in Patients Unresponsive to Lamivudine |
| 06/26/2008 11:10:57 AM | |
| European Commission Approves Shortened Treatment With Peginterferon Alfa-2a Plus Ribavirin for Specific Hepatitis C Patients |
| 06/06/2008 07:19:53 PM | |
| Sirolimus Increases Graft Survival in Orthotopic Liver Transplant Recipients: Presented at ATC |
| 06/06/2008 04:55:26 PM | |
| Researchers Pinpoint Risk Factors for Infections Post-Liver Transplantation |
| 05/20/2008 02:02:28 PM | |
| Low-Dose Tenofovir Shows Efficacy in Patients With Lamivudine-Resistant Hepatitis B Virus: Presented at IM |
| 05/19/2008 04:54:53 PM | |
| Hepatitis C-Positive Patients Treated With Rituximab Are at Increased Risk of Liver Toxicities: Presented at IM |
| 05/15/2008 09:57:13 AM | |
| Fluvastatin May Lower Viral Load for Hepatitis C Patients |
| 04/30/2008 02:32:49 PM | |
| Low-Dose Pegylated Interferon Regimen Shows Sustained Viral Response in Patients With Hepatitis C Genotype 1: Presented at EASL |
| 04/29/2008 03:39:21 PM | |
| Tenofovir Active in Previously Treated Chronic Hepatitis B, Including Adefovir-Resistant Virus: Presented at EASL |
| 04/29/2008 03:33:30 PM | |
| Taribavirin Comparable in Efficacy to Ribavirin and Results in Less Anaemia in Patients With Chronic Hepatitis C: Presented at EASL |
| 04/29/2008 03:15:18 PM | |
| Nitazoxanide Demonstrates Activity in Treatment-Naive Patients With Hepatitis C Virus Genotype 4: Presented at EASL |
| 04/29/2008 02:47:39 PM | |
| R7128 is Safe, Effective in Short-Term for Patients With Hepatitis C Virus Genotype 1: Presented at EASL |
| 04/29/2008 02:38:18 PM | |
| Telaprevir-Based Therapy Provides High Rapid Viral Response in Treatment-Naive Patients With Genotype 1 Hepatitis C Virus: Presented at EASL |
| 04/29/2008 02:25:15 PM | |
| Boceprevir Active, Well-Tolerated in Treatment-Naive Patients With HCV-1: Presented at EASL |
| 04/28/2008 03:59:08 PM | |
| Sorafenib Safe in Patients With Unresectable Hepatocellular Carcinoma and Advanced Liver Cirrhosis: Presented at EASL |
| 04/28/2008 09:02:43 AM | |
| Adefovir Switch to Tenofovir at 48 Weeks Improves Viral Suppression in Patients With Chronic Hepatitis B: Presented at EASL |
| 04/25/2008 05:17:45 PM | |
| Tenofovir Disoproxil Fumarate Approved in Europe for Treatment of Chronic Hepatitis B |
| 04/25/2008 11:20:14 AM | |
| Peg-Interferon Improves Event-Free Survival Compared With Colchicine in Patients With Cirrhosis and Portal Hypertension: Presented at EASL |
| 04/21/2008 06:15:27 PM | |
| Sunitinib Slows Tumour Growth and Spread of Advanced Liver Cancer: Presented at AACR |
| 04/21/2008 06:13:35 PM | |
| Lapatinib Shows Promise for Advanced Hepatocellular Carcinoma: Presented at AACR |
| 04/08/2008 04:00:46 PM | |
| Combination Therapy Improves Survival in Patients With Advanced Hepatocellular Cancer |
| 03/27/2008 05:21:40 PM | |
| Combining Peginterferon With Weight-Based Ribavirin Increases Virologic Response in Hepatitis C |
| 03/25/2008 04:14:03 PM | |
| Entecavir Has Low Resistance Rates After 5-Year Treatment of Chronic Hepatitis B |
| 03/25/2008 08:17:37 AM | |
| Low 1-Year Survival Observed With Radioactive Spheres in Advanced Hepatocellular Carcinoma: Presented at SIR |
| 03/20/2008 03:41:45 PM | |
| Yttrium-90 Microsphere Treatment-Induced Gastrointestinal Ulcers in Patients With Liver Tumours Are Preventable: Presented at SIR |
| 03/12/2008 11:25:56 AM | |
| Sorafenib Added to Guidelines for Treatment of Hepatocellular Carcinoma: Presented at NCCN |
| 03/12/2008 11:04:36 AM | |
| Guidelines Support Ablation Techniques for Unresectable Liver Cancer: Presented at NCCN |
| 02/19/2008 12:23:56 PM | |
| Liver Injury Rate With Duloxetine Similar to Other Therapeutic Agents: Presented at AAPM |
| 02/08/2008 05:58:36 PM | |
| Sorafenib Plus Doxorubicin May Offer Better Time to Progression Than Doxorubicin Alone in Advanced Hepatocellular Carcinoma: Presented at ICACT |
| 02/08/2008 12:30:10 PM | |
| Boosted Interferon Achieves Sustained Virologic Response With Reduced Liver Complications in Patients With HIV/Hepatitis C: Presented at CROI |
| 02/06/2008 03:09:05 PM | |
| Low Risk of Hepatotoxicity With Once-Daily Nevirapine: Presented at CROI |
| 01/29/2008 09:13:12 AM | |
| Two-Stage Hepatectomy Is Potentially Curative for Patients With Irresectable Liver Metastases From Colorectal Cancer: Presented at ASCO-GI |
| 01/27/2008 11:00:55 AM | |
| Patients at Risk for Liver Cancer Should Be Screened With Ultrasound: Presented at ASCO-GI |
| 12/28/2007 12:48:18 PM | |
| Eltrombopag Effective for Hepatitis C Patients With Low Blood-Platelet Counts |
| 12/28/2007 09:25:58 AM | |
| Researchers Determine Weight-Based Dosing Key to Optimal Treatment |
| 12/18/2007 02:27:19 PM | |
| HCV Entry Pathway as a Target for Drug Development: Presented at HEP-DART |
| 12/18/2007 11:25:18 AM | |
| Strategies for Development of New Anti-HCV Therapies: Presented at HEP-DART |
| 12/18/2007 09:23:44 AM | |
| Viral Hepatitis a Major Public Health Problem: Presented at HEP-DART |
| 12/17/2007 09:47:10 AM | |
| Lipid Droplets Are Necessary for Production of Infectious HCV: Presented at HEP-DART |
| 12/14/2007 03:59:36 PM | |
| New Models Describe HBV and HCV Viral Decay Under Treatment: Presented at HEP-DART |
| 12/03/2007 06:35:24 PM | |
| Laser Ablation of Breast Cancer Metastases to Liver Appears to Extend Survival: Presented at RSNA |
| 11/30/2007 02:19:06 PM | |
| Radiofrequency Ablation Is Safe for Liver Cancer Lesions Close to the Diaphragm: Presented at RSNA |
| 11/27/2007 02:19:28 PM | |
| Drug Boosts Platelets in Hepatitis C Patients |
| 11/26/2007 02:12:57 PM | |
| Good Liver Function, Small Tumours Result in Long-Term Survival in Hepatocellular Cancer Treated With Percutaneous Laser Ablation: Presented at RSNA |
| 11/19/2007 12:58:28 PM | |
| FDA Approves Nexavar for Treatment of Liver Cancer |
| 11/15/2007 11:50:56 AM | |
| Pegintron(TM) (peginterferon alfa-2b) and Rebetol(R) (ribavirin) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy |
| 11/14/2007 10:01:03 AM | |
| Optimal Systemic and Splanchnic Hemodynamic State After Living-Donor Liver Transplantation |
| 11/14/2007 09:51:52 AM | |
| Number of Cases of Most Vaccine-Preventable Diseases in US at All-Time Low |
| 11/13/2007 03:11:53 PM | |
| Nexavar Becomes First Approved Systemic Treatment of Hepatocellular Carcinoma in Europe |
| 11/09/2007 02:07:09 PM | |
| Tumour Marker Predicts Malignancy in Biliary-Tract Cancers: Presented at AASLD |
| 11/09/2007 01:52:33 PM | |
| Hepatitis C and Decompensated Cirrhosis Improve With Combination Therapy, Individualized Approach: Presented at AASLD |
| 11/08/2007 04:30:18 PM | |
| "Real Life" Success Treating Chronic Hepatitis C Can Match That in Clinical Trials: Presented at AASLD |
| 11/08/2007 03:50:41 PM | |
| Some Genotype 3 Hepatitis C Patients May Require Increased Doses or Longer Treatment: Presented at AASLD |
| 11/08/2007 03:47:43 PM | |
| Psychiatric Disorders Do Not Reduce Effectiveness of Hepatitis C Treatment: Presented at AASLD |
| 11/07/2007 12:49:47 PM | |
| Similar Efficacy Shown For Pegylated Interferon Alfa-2b, Pegylated Interferon Alfa-2a for Hepatitis C: Presented at AASLD |
| 11/07/2007 12:47:55 PM | |
| Seroclearance of Hepatitis B s Antigen Helps Prevent Liver Cancer: Presented at AASLD |
| 11/07/2007 10:52:29 AM | |
| Consensus Interferon in Hepatitis C Is an Option for Those Non-Responsive to Peginterferon/Ribavrin: Presented at AASLD |
| 11/07/2007 10:31:37 AM | |
| Peginterferon Alfa-2a Plus Ribavirin Safe and Effective In Patients With Both Hepatitis C and B: Presented at AASLD |
| 11/07/2007 10:03:28 AM | |
| Early Viral Replication Is Predictive of Long-Term Outcome With Telbivudine in Chronic Hepatitis B Infection: Presented at AASLD |
| 11/07/2007 09:29:54 AM | |
| Long-Term Entecavir Represses Hepatitis B Virus in Group of Patients: Presented at AASLD |
| 11/06/2007 01:28:57 PM | |
| Lab Data Reveal Risk for Liver Complications in Patients With Chronic Hepatitis B: Presented at AASLD |
| 11/06/2007 01:26:50 PM | |
| Increasing Hepatitis B Treatment With Adefovir and Entecavir Drive Resistance Patterns in the United States: Presented at AASLD |
| 11/05/2007 03:25:02 PM | |
| Drug Users With Hepatitis C Virus Can Achieve a Sustained Virologic Response With Standard Treatment: Presented at AASLD |
| 11/05/2007 03:21:53 PM | |
| Opioid Maintenance Therapy Not Related to Treatment Failure for Hepatitis C: Presented at AASLD |
| 11/05/2007 03:17:50 PM | |
| Hepatitis C Virus Eradication Linked to Sustained Response After Treatment With Either Interferon alfa 2b or Pegylated Interferon alfa-2b Plus Ribavirin: Presented at AASLD |
| 11/05/2007 03:13:31 PM | |
| Danazol Increases Platelet Counts in Thrombocytopenic Patients With Chronic Hepatitis C or Cirrhosis: Presented at AASLD |
| 11/05/2007 03:02:00 PM | |
| Pegylated Interferon Alfa-2a Monotherapy Efficacious in Treating Dialysis Patients With Hepatitis C: Presented at AASLD |
| 11/05/2007 02:55:47 PM | |
| Patients With Hepatitis C and HIV Respond to Hepatitis Treatment: Presented at AASLD |
| 11/05/2007 02:24:36 PM | |
| Plasma Exchange Effective in Treating Hepatitis C-Associated Cryoglobulinemia: Presented at AASLD |
| 11/02/2007 06:20:27 PM | |
| Predicting Survival After Liver Transplantation |
| 11/02/2007 02:57:54 PM | |
| 24-Week Course of Interferon-Alpha Therapy Prolongs Survival in Patients Hepatitis C Virus |
| 11/02/2007 08:21:29 AM | |
| Need for Liver Transplants Decreasing in U.S. |
| 11/01/2007 09:33:54 AM | |
| A New Monoclonal Antibody, VEGF Inhibitor Is Active in Patients with Advanced Solid Tumours: Presented at AACR-NCI-EORTC |
| 10/30/2007 11:26:00 AM | |
| Nexavar® (Sorafenib) Approved for Hepatocellular Carcinoma in Europe |
| 10/24/2007 04:59:10 PM | |
| More Precise Criteria Needed for Nonalcoholic Fatty Liver Disease: Presented at ASCP |
| 10/24/2007 12:30:39 PM | |
| Gallstones Associated With Nonalcoholic Steatohepatitis (Nash) and Metabolic Syndrome: Presented at ASCP |
| 10/24/2007 12:01:46 PM | |
| CT-Guided Fine-Needle Aspiration Provides Accuracy for Liver Biopsy: Presented at ASCP |
| 10/23/2007 05:44:16 PM | |
| MRI Can Predict Liver Fibrosis |
| 10/23/2007 04:45:07 PM | |
| More Accurate Diagnosis of Some Liver Diseases Using Alpha-Fetoprotein (AFP) Levels: Presented at ASCP |
| 10/16/2007 03:35:32 PM | |
| Are Analgesics Dangerous to Cirrhotic Patients at Risk for Decompensation?: Presented at ACG |
| 10/12/2007 11:23:36 AM | |
